Iarossi, G. and Copp, A.M. (2022) Dexamethasone Intravitreal Implant (Ozurdex) in Paediatric Patients with Non-Infectious Intermediate Uveitis and Related Cystoid Macular Oedema: Evaluation of Macular Morphology and Function with Six-Month Follow-Up; A Deeper Role of MfERG? Ocular Immunology and Inflammation, 30, 234-240.
https://doi.org/10.1080/09273948.2020.1794011

has been cited by the following article:

• TITLE: Progress in the Use of Glucocorticoids and Biological Agents in Non-Infectious Uveitis

  AUTHORS: Yuxuan Liu, Xunyu Zou, Shizhou Cheng, Zuhai Zhang

  KEYWORDS: Non-Infectious Uveitis, Glucocorticoids, Biological Agents

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.12 No.2, February 7, 2024

  ABSTRACT: One of the main immune-mediated diseases that lead to avoidable blindness is non-infectious uveitis. Glucocorticoids are the first-line therapy choice for noninfectious uveitis; however, biologics are also showing promise in the management of this condition. The description of glucocorticoid and biologic usage in non-infectious uveitis is the main topic of this paper.